Urokinase induced fibrinolysis in thromboelastography: a model for studying fibrinolysis and coagulation in whole blood

被引:29
作者
Gallimore, MJ [1 ]
Harris, SL
Tappenden, KA
Winter, M
Jones, DW
机构
[1] Kent & Canterbury Hosp, Kent Haemophilia Ctr, Canterbury CT1 3NG, Kent, England
[2] Univ Kent, Dept Biosci, Canterbury, Kent, England
[3] Natl Hosp Norway, Inst Surg Res, Oslo, Norway
关键词
coagulation; contact activation; factor XIIa; fibrinolysis; kallikrein; thromboelastography; urokinase;
D O I
10.1111/j.1538-7836.2005.01615.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The contact system (CS) proteins, factor XII and prekallikrein are thought to have roles in blood coagulation and fibrinolysis. Recent research has suggested that the CS proteins might be more important in fibrinolysis and cell function than ill coagulation. Most Studies oil fibrinolysis have used plasma or euglobulinl assays, ignoring the influence of cellular elements of blood oil the fibrinolytic process. Objective and methods: In order to Study both coagulation and fibrinolysis in whole blood (WB), we have developed a thromboelastography (TEG) assay to investigate both coagulation and fibrinolysis in the same blood sample. In this assay, named Urokinase (UK) induced fibrinolysis in thromboelastography (UKIFTEG), TEG is performed oil recalcified citrated WB in the presence of UK. Large variations in Ly60 (percentage lysis 60 min after clot formation) were obtained between different donors with the same UK. concentration. The UKIFTEG assay was therefore performed using UK concentrations that gave Ly60 values in the approximate range of 20-40%. Results: The effect of CS activation was investigated in the presence or absence of celite (10 mg mL(-1) blood). Celite shortened the clotting time (CT), and increased Ly60 values. Factor XIIa (FXIIa) and plasma kallikrein (KK) produced concentration dependent reductions ill CT (significant at concentrations of 1303 and 2600 ng mL(-1) blood, respectively) and increased Ly60 Values (significant at concentrations of 652 and 1300 ng mL(-1) blood, respectively). Conclusions: Our results show that CS activation and both FXIIa and KK produce reductions in clotting time and enhanced fibrinolysis in UKIFTEG.
引用
收藏
页码:2506 / 2513
页数:8
相关论文
共 29 条
[1]   Fibrinolytic properties of activated FXII [J].
Braat, EAM ;
Dooijewaard, G ;
Rijken, DC .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (03) :904-911
[2]   EFFECT OF DEXTRAN ON FIBRINOLYSIS INHIBITION ACTIVITY IN SERUM [J].
CARLIN, G ;
SALDEEN, T .
THROMBOSIS RESEARCH, 1978, 12 (06) :1165-1175
[3]  
Chandler WL, 1995, SEMIN THROMB HEMOST, V21, P1
[4]   Hemostatic analysis of a patient with hereditary angioedema undergoing coronary artery bypass grafting [J].
Chaney, JD ;
Adair, TM ;
Lell, WA ;
McGiffin, DC ;
Nielsen, VG .
ANESTHESIA AND ANALGESIA, 2001, 93 (06) :1480-1482
[5]   Contact system: A vascular biology modulator with anticoagulant, Profibrinolytic, antiadhesive, and proinflammatory attributes [J].
Colman, RW ;
Schmaier, AH .
BLOOD, 1997, 90 (10) :3819-3843
[6]  
Colman RW, 1999, THROMB HAEMOSTASIS, V82, P1568
[7]   EFFECT OF DILUENTS ON BLOOD CLOT LYSIS [J].
GALLIMORE, MJ .
JOURNAL OF CLINICAL PATHOLOGY, 1967, 20 (03) :234-+
[8]  
GALLIMORE MJ, 1971, THROMB DIATH HAEMOST, V26, P295
[9]   Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis [J].
Gallimore, MJ ;
Harris, SL ;
Jones, DW ;
Winter, M .
THROMBOSIS RESEARCH, 2004, 114 (02) :91-96
[10]   PURIFICATION OF A HUMAN-PLASMA KALLIKREIN WITH WEAK PLASMINOGEN ACTIVATOR ACTIVITY [J].
GALLIMORE, MJ ;
FAREID, E ;
STORMORKEN, H .
THROMBOSIS RESEARCH, 1978, 12 (03) :409-420